TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial.

Terry A Day et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.